ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO956

Association between Electrical Impedance Vectors and Sarcopenia in Patients with CKD

Session Information

Category: Health Maintenance, Nutrition, and Metabolism

  • 1500 Health Maintenance, Nutrition, and Metabolism

Authors

  • Ortiz, Ailema Janeth Gonzalez, Instituto Nacional de Pediatria, Mexico City, Mexico City, Mexico
  • Rosales Arreola, Laura Fernanda, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
  • Callejas, Ana, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
  • Miranda, Paola V., Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
  • Lopez-Cisneros, Sonia, Instituto Nacional de Geriatria, Ciudad de Mexico, Ciudad de México, Mexico
  • Espinosa-Cuevas, Angeles, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
Background

Sarcopenia, characterized by the progressive loss of muscle quality and quantity, affecting quality of life, commonly occurs in patients with Chronic Kidney Disease. Bioelectric Impedance (IBE) and IBE Vectors (VIBE) allow the identification of decreased muscle mass and might identify patients with sarcopenia. We aimed to identify the association between VIBE and sarcopenia in patients with CKD (G3-G5) and HD.

Methods

This cross-sectional study included adult patients over 18 years with ESRD and replacement treatment. Bioelectrical impedance measurements were performed, and body composition was evaluated. The EWGSOP2 criteria were used to diagnose sarcopenia.

Results

The prevalence of sarcopenia was 11.6% in CKD (G3-G5) and 14.8% in HD. VIBE patterns indicated that sarcopenia was located outside the tolerance ellipses in the right quadrant in both groups (p < 0.05). In the HD population, the phase angle and Impedance Ratio (IR) were lower in patients with CKD on HD (p 0.03). In CKD (G3-G5), age was higher in the sarcopenia group (p < 0.05), and they had DM (p 0.03) and lower creatinine concentration (p 0.02).

Conclusion

The results suggest that VIBE, phase angle, and IR could be helpful tools for identifying sarcopenia in patients with CKD and HD. These measurements could provide valuable information for the early detection and management of sarcopenia in this population.